Frequency of Hypermobility-Related Problems in Patients With Anorexia Nervosa
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age13-25
SponsorVastra Gotaland Region
About this trial
The purpose of this study is to examine the frequense of generalized hypermobility and pain in patients with Anorexia Nervosa. The study further explores two main questions: (1) whether generalized hypermobility may be an explanatory factor for pain in some patients with Anorexia Nervosa, and (2) whether temporomandibular joint problems (such as instability, pain, difficulties opening the mouth, locking, or clicking) contribute to eating difficulties in certain individuals with Anorexia Nervosa.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Anorexia Nervosa (ICD-10 F50.0), or
Atypical Anorexia Nervosa (ICD-10 F50.1)
Currently receiving treatment or scheduled to receive treatment
Disqualifiers
Severe cognitive impairment
Insufficient Swedish language skills that make it impossible to provide informed consent and prevent answering study questions
Pregnancy and up to one year postpartum
Trial population
Patients at the Eating Disorders Center for Children and Young Adults in Gothenburg.
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
100 Participants
are grouped into 1 trial groupGroup A: Female patients diagnosed with Anorexia Nervosa or Atypical Anorexia Nervosa, aged 13-25 years.
Trial outcomes
Primary outcomes
1
Joint hypermobility
Joint mobility will be assessed according to the Beighton score using a goniometer.
Time frame
One-time assessment at baseline (Day 0, at the inclusion visit).2
5-part questionnaire
Participants over the age of 18 will also complete the 5-part questionnaire regarding historical hypermobility.
Time frame
One-time questionnaire at baseline (Day 0, after clinical examination).Secondary outcomes
1
Joint pain
The Numeric Rating Scale (NRS) is a self-assessment tool used to describe the patient's perceived pain intensity. The patient marks the intensity on a line with eleven points, ranging from 0 to 10. The endpoints represent 0 = 'no pain' and 10 = 'worst imaginable pain.'
Time frame
One-time questionnaire at baseline (Day 0, after clinical examination).2
Temporomandibular joint problems
Screening questions regarding temporomandibular joint problems. The short version of the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) classification system will be used.
Time frame
One-time questionnaire at baseline (Day 0, after clinical examination).3
Pain drawing
Participant marks areas of perceived pain on a schematic human body figure.
Time frame
One-time questionnaire at baseline (Day 0, after clinical examination).Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: